Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease
Mohammad Shadab Siddiqui(Virginia Commonwealth University), Arun J. Sanyal(Virginia Commonwealth University), Manal F. Abdelmalek(Mayo Clinic), David E. Kleiner(National Institutes of Health), Raj Vuppalanchi(University of Pennsylvania), Danielle Brandman(University of California, San Francisco), Rohit Loomba(University of California San Diego), Mark L. Van Natta(Johns Hopkins University), Edward Doo(National Institutes of Health), Brent A. Neuschwander‐Tetri(Saint Louis University), Naga Chalasani(Indiana University – Purdue University Indianapolis), Kris V. Kowdley(Liver Institute Northwest), James Tonascia(Johns Hopkins University), Erin Hallinan(Johns Hopkins University), Srinivasan Dasarathy(Cleveland Clinic)
Cited by 593
Related Papers
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
|Hepatology|2017|7.2k
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
|New England Journal of Medicine|2010|3.3k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k